Ftse Mib
36.200,72
0,00%
DAX
21.385,62
0,00%
S&P 500
6.101,24
-0,29%
NASDAQ
19.954,30
-0,50%
Bitcoin
99.005,41
-5,41%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Tempest Therpeutics Inc (TPST) Tempest Therpeutics Inc (TPST) Notizie

Tempest Therpeutics Inc

TPST
0,9501
0,00 (0,00%)
27 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/1/202522:35EDGAR2Form S-3/A - Registration statement under Securities Act of..
06/1/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202523:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202514:00GLOBETempest Receives Orphan Drug Designation from the U.S. Food..
31/12/202422:01EDGAR2Form 8-K - Current report
06/12/202422:30GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
06/12/202422:15EDGAR2Form 8-K - Current report
25/11/202422:30GLOBETempest to Participate in the Piper Sandler 36th Annual ..
12/11/202422:41EDGAR2Form DEF 14A - Other definitive proxy statements
12/11/202422:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:21GLOBETempest Reports Third Quarter 2024 Financial Results..
12/11/202422:16EDGAR2Form 8-K - Current report
12/11/202414:00GLOBETempest Receives FDA Study May Proceed for Pivotal Phase 3..
29/10/202421:15EDGAR2Form PRE 14A - Other preliminary proxy statements
10/10/202413:30EDGAR2Form 8-A12B/A - Registration of securities [Section 12(b)]:..
10/10/202413:16EDGAR2Form 8-K - Current report
10/10/202413:01GLOBETempest Announces Agreement with Roche to Support..
10/10/202413:00GLOBETempest Extends Limited Duration Stockholder Rights Plan
20/9/202422:30GLOBETempest Reports Inducement Grants Under Nasdaq Listing Rule..
18/9/202414:00GLOBETempest Further Strengthens Leadership Team with Appointment..
05/9/202414:00GLOBETempest to Present at the H.C. Wainwright 26th Annual Global..
23/8/202422:30GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
21/8/202414:00GLOBETempest Announces the Appointment of Troy M. Wagner as Vice..
15/8/202414:00GLOBETempest Announces Successful End-of-Phase 2 Meeting with FDA..
13/8/202414:03EDGAR2Form 144 - Report of proposed sale of securities
13/8/202402:59EDGAR2Form SC 13D/A - General Statement of Acquisition of..
09/8/202421:41EDGAR2Form 144 - Report of proposed sale of securities
08/8/202422:56GLOBETempest Reports Second Quarter 2024 Financial Results and..
08/8/202422:44EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:33EDGAR2Form 8-K - Current report
19/7/202422:31EDGAR2Form S-3 - Registration statement under Securities Act of..
08/7/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/6/202414:32EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/6/202414:13EDGAR2Form 8-K - Current report
20/6/202414:00GLOBETempest Unveils New Survival Data for Amezalpat (TPST-1120)..
19/6/202400:22GLOBETempest to Report New Data from Global Randomized..
15/6/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:41EDGAR2Form 8-K - Current report
07/6/202410:30GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
21/5/202414:00GLOBETempest to Participate in Upcoming Investor Conferences
13/5/202422:54EDGAR2Form SC 13D/A - General statement of acquisition of..
09/5/202422:29EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:29GLOBETempest Reports First Quarter 2024 Financial Results and..
09/5/202422:25EDGAR2Form 8-K - Current report
26/4/202422:05GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
09/4/202414:00GLOBETempest Reports New Preclinical Data for TPST-1120 in RCC at..
04/4/202414:00GLOBETempest Announces Publication of Positive Data from Phase 1..
19/3/202421:25GLOBETempest Reports Year End 2023 Financial Results and Provides..
Apertura: Min: Max:
Chiusura: 0,9501

La tua Cronologia

NASDAQ
TPST
Tempest Therpeutics
BIT
S28307
Societe Generale Effekten
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network